261 related articles for article (PubMed ID: 36613762)
1. Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours.
Barszczewska-Pietraszek G; Drzewiecka M; Czarny P; Skorski T; Śliwiński T
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613762
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia Cells.
Sullivan-Reed K; Toma MM; Drzewiecka M; Nieborowska-Skorska M; Nejati R; Karami A; Wasik MA; Sliwinski T; Skorski T
Mol Cancer Res; 2023 Oct; 21(10):1017-1022. PubMed ID: 37358557
[TBL] [Abstract][Full Text] [Related]
3. Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.
Ceccaldi R; Liu JC; Amunugama R; Hajdu I; Primack B; Petalcorin MI; O'Connor KW; Konstantinopoulos PA; Elledge SJ; Boulton SJ; Yusufzai T; D'Andrea AD
Nature; 2015 Feb; 518(7538):258-62. PubMed ID: 25642963
[TBL] [Abstract][Full Text] [Related]
4. DNA polymerase theta (Polθ) - an error-prone polymerase necessary for genome stability.
Brambati A; Barry RM; Sfeir A
Curr Opin Genet Dev; 2020 Feb; 60():119-126. PubMed ID: 32302896
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP) ribose polymerase promotes DNA polymerase theta-mediated end joining by activation of end resection.
Luedeman ME; Stroik S; Feng W; Luthman AJ; Gupta GP; Ramsden DA
Nat Commun; 2022 Aug; 13(1):4547. PubMed ID: 35927262
[TBL] [Abstract][Full Text] [Related]
6. Polymerase theta-helicase promotes end joining by stripping single-stranded DNA-binding proteins and bridging DNA ends.
Schaub JM; Soniat MM; Finkelstein IJ
Nucleic Acids Res; 2022 Apr; 50(7):3911-3921. PubMed ID: 35357490
[TBL] [Abstract][Full Text] [Related]
7. Sequential requirements for distinct Polθ domains during theta-mediated end joining.
Fijen C; Drogalis Beckham L; Terino D; Li Y; Ramsden DA; Wood RD; Doublié S; Rothenberg E
Mol Cell; 2024 Apr; 84(8):1460-1474.e6. PubMed ID: 38640894
[TBL] [Abstract][Full Text] [Related]
8. Synthetic Lethality Targeting Polθ.
Drzewiecka M; Barszczewska-Pietraszek G; Czarny P; Skorski T; Śliwiński T
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741863
[TBL] [Abstract][Full Text] [Related]
9. Polθ is phosphorylated by PLK1 to repair double-strand breaks in mitosis.
Gelot C; Kovacs MT; Miron S; Mylne E; Haan A; Boeffard-Dosierre L; Ghouil R; Popova T; Dingli F; Loew D; Guirouilh-Barbat J; Del Nery E; Zinn-Justin S; Ceccaldi R
Nature; 2023 Sep; 621(7978):415-422. PubMed ID: 37674080
[TBL] [Abstract][Full Text] [Related]
10. Targeting Polymerase Theta (POLθ) for Cancer Therapy.
Patterson-Fortin J; D'Andrea AD
Cancer Treat Res; 2023; 186():285-298. PubMed ID: 37978141
[TBL] [Abstract][Full Text] [Related]
11. POLθ-mediated end joining is restricted by RAD52 and BRCA2 until the onset of mitosis.
Llorens-Agost M; Ensminger M; Le HP; Gawai A; Liu J; Cruz-García A; Bhetawal S; Wood RD; Heyer WD; Löbrich M
Nat Cell Biol; 2021 Oct; 23(10):1095-1104. PubMed ID: 34616022
[TBL] [Abstract][Full Text] [Related]
12. The helicase domain of Polθ counteracts RPA to promote alt-NHEJ.
Mateos-Gomez PA; Kent T; Deng SK; McDevitt S; Kashkina E; Hoang TM; Pomerantz RT; Sfeir A
Nat Struct Mol Biol; 2017 Dec; 24(12):1116-1123. PubMed ID: 29058711
[TBL] [Abstract][Full Text] [Related]
13. Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaks.
Murmann-Konda T; Soni A; Stuschke M; Iliakis G
Mutat Res Genet Toxicol Environ Mutagen; 2021 Jul; 867():503372. PubMed ID: 34266628
[TBL] [Abstract][Full Text] [Related]
14. A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient Tumors.
Zhou J; Gelot C; Pantelidou C; Li A; Yücel H; Davis RE; Färkkilä A; Kochupurakkal B; Syed A; Shapiro GI; Tainer JA; Blagg BSJ; Ceccaldi R; D'Andrea AD
Nat Cancer; 2021 Jun; 2(6):598-610. PubMed ID: 34179826
[TBL] [Abstract][Full Text] [Related]
15. Mechanism, cellular functions and cancer roles of polymerase-theta-mediated DNA end joining.
Ramsden DA; Carvajal-Garcia J; Gupta GP
Nat Rev Mol Cell Biol; 2022 Feb; 23(2):125-140. PubMed ID: 34522048
[TBL] [Abstract][Full Text] [Related]
16. Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers.
Patterson-Fortin J; Bose A; Tsai WC; Grochala C; Nguyen H; Zhou J; Parmar K; Lazaro JB; Liu J; McQueen K; Shapiro GI; Kozono D; D'Andrea AD
Cancer Res; 2022 Oct; 82(20):3815-3829. PubMed ID: 35972384
[TBL] [Abstract][Full Text] [Related]
17. Polymerase θ Coordinates Multiple Intrinsic Enzymatic Activities during DNA Repair.
Zahn KE; Jensen RB
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573292
[TBL] [Abstract][Full Text] [Related]
18. RHINO directs MMEJ to repair DNA breaks in mitosis.
Brambati A; Sacco O; Porcella S; Heyza J; Kareh M; Schmidt JC; Sfeir A
Science; 2023 Aug; 381(6658):653-660. PubMed ID: 37440612
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of HR and NHEJ activities via CRISPR/Cas9-induced oligodeoxynucleotide-mediated DSB repair.
Du J; Yin N; Xie T; Zheng Y; Xia N; Shang J; Chen F; Zhang H; Yu J; Liu F
DNA Repair (Amst); 2018 Oct; 70():67-71. PubMed ID: 30212742
[TBL] [Abstract][Full Text] [Related]
20. Polθ promotes the repair of 5'-DNA-protein crosslinks by microhomology-mediated end-joining.
Chandramouly G; Liao S; Rusanov T; Borisonnik N; Calbert ML; Kent T; Sullivan-Reed K; Vekariya U; Kashkina E; Skorski T; Yan H; Pomerantz RT
Cell Rep; 2021 Mar; 34(10):108820. PubMed ID: 33691100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
